2016
DOI: 10.1016/j.cimid.2016.09.003
|View full text |Cite
|
Sign up to set email alerts
|

Changes in serum biomarkers of oxidative stress after treatment for canine leishmaniosis in sick dogs

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
13
0

Year Published

2018
2018
2020
2020

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 22 publications
(15 citation statements)
references
References 32 publications
2
13
0
Order By: Relevance
“…The ELISA used for quantitative determination of adrenaline (epinephrine) (Adrenaline Research ELISA™) had intra-assay and inter-assay variability less than 10% and a limit of detection of 0.25 ng/ml. Total oxidant status, paraoxonase 1 (PON1) and total antioxidant capacity (TAC; measured by trolox equivalent antioxidant capacity) were analysed following published methods [27][28][29]. All determinations of oxidative stress biomarkers were performed in an automated biochemistry analyser (Olympus AU600 Automatic Chemistry Analyzer, Olympus Europe GmbH, Germany).…”
Section: Plos Onementioning
confidence: 99%
“…The ELISA used for quantitative determination of adrenaline (epinephrine) (Adrenaline Research ELISA™) had intra-assay and inter-assay variability less than 10% and a limit of detection of 0.25 ng/ml. Total oxidant status, paraoxonase 1 (PON1) and total antioxidant capacity (TAC; measured by trolox equivalent antioxidant capacity) were analysed following published methods [27][28][29]. All determinations of oxidative stress biomarkers were performed in an automated biochemistry analyser (Olympus AU600 Automatic Chemistry Analyzer, Olympus Europe GmbH, Germany).…”
Section: Plos Onementioning
confidence: 99%
“…Hence, in this study a comprehensive panel of sbOS to evaluate both TAC and oxidative damage was selected. In addition, the biomarkers evaluated in the present study (CUPRAC, FRAP, FOX, PON1, TEAC‐A, TEAC‐B and THIOL) have been proven useful to evaluate involvement of OS in the pathogenesis in different chronic systemic diseases in humans, and in dogs . In dogs, OS was demonstrated by a significantly lower antioxidant capacity in dogs with clinical ehrlichiosis and leishmaniosis, when compared to healthy dogs .…”
Section: Discussionmentioning
confidence: 83%
“…Data in the veterinary literature regarding oxidative status in canine atopic diseases is limited . We used selected serum biomarkers of OS (sbOS) that have been validated in normal dogs and in dogs with different systemic chronic diseases . To the best of the authors’ knowledge, sbOS have not been described in canine AD.…”
Section: Introductionmentioning
confidence: 99%
“…The evaluation of antioxidant capacity and antioxidant enzymes in plasma were performed following the methods described in [ 31 ] Glutathione peroxidase (GPx) assay was performed based on the method described by Paglia and Valentine [ 32 ] with a commercially available kit (Ransel test kit, Randox Laboratories Ltd., Crumlin, County Antrim, UK). Catalase activity was determined according to Johansson and Borg [ 33 ].…”
Section: Methodsmentioning
confidence: 99%